TAVR Chugging Along at 5 Years in SURTAVI Trial

(MedPage Today) -- Researchers keeping an eye on the long-term outcomes of people undergoing transcatheter aortic valve replacement (TAVR) reported encouraging results in both clinical and economic terms, according to two reports from the Transcatheter...